Dihydrotestosterone (DHT) Test at Lahore PCR Lab

Dihydrotestosterone (DHT) Test at Lahore PCR Lab

The Dihydrotestosterone (DHT) test is a highly specialized endocrine investigation designed to measure the concentration of dihydrotestosterone in the blood. DHT is a biologically active androgenic hormone derived from testosterone through the enzymatic action of 5-alpha-reductase. Although it is present in lower circulating concentrations than testosterone, DHT is significantly more potent due to its higher affinity for androgen receptors and slower dissociation rate. This hormone plays a critical role in the development of male secondary sexual characteristics during puberty, the physiology of the prostate gland, and the regulation of hair follicle growth cycles in both men and women. At Lahore PCR Lab, located in the heart of Lahore, Pakistan, this test is performed using advanced automated immunoassay platforms and molecular-grade diagnostic systems to ensure the highest degree of clinical precision and reproducibility.

Understanding the clinical utility of the DHT test requires an appreciation of its physiological impact. In males, DHT is primary to the development of the external genitalia in utero and drives prostate growth, facial hair development, and sebum production during adolescence. In females, while androgens are present in much smaller quantities, abnormal elevations in DHT can lead to significant clinical manifestations, including hirsutism, severe acne, and menstrual irregularities. Lahore PCR Lab provides this quantitative assay to assist endocrinologists, dermatologists, gynecologists, and urologists in diagnosing complex hormonal disorders, monitoring androgen deprivation therapies, and evaluating hair loss patterns. By utilizing state-of-the-art laboratory infrastructure, Lahore PCR Lab delivers accurate biochemical profiles that serve as a cornerstone for personalized therapeutic interventions.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the utmost accuracy and avoid analytical interference, patients undergoing a Dihydrotestosterone (DHT) test at Lahore PCR Lab must adhere to specific pre-analytical guidelines. Proper preparation minimizes physiological fluctuations and external interferences that could compromise the test results:

• Fasting Requirements: While a strict fast is not universally mandatory for all DHT assays, a morning fasting sample (8 to 12 hours of water-only fasting) is highly recommended. This helps standardize the collection process and minimizes dietary lipid interference with the laboratory instrumentation.
• Timing of Collection: Androgen levels exhibit diurnal variation, typically peaking in the early morning hours. It is highly recommended that blood collection be performed between 7:00 AM and 10:00 AM to ensure results are comparable to established clinical reference ranges.
• Medication and Supplement Review: Patients must inform their referring physician and the laboratory staff at Lahore PCR Lab of all medications, hormones, and dietary supplements they are currently taking. Specifically, 5-alpha-reductase inhibitors (such as finasteride or dutasteride), testosterone replacement therapy (TRT), anabolic steroids, and oral contraceptives can profoundly alter DHT levels.
• Biotin Warning: High doses of Biotin (Vitamin B7), frequently found in hair, skin, and nail supplements, can severely interfere with streptavidin-biotin-based immunoassays, leading to falsely elevated or falsely depressed results. Patients must discontinue biotin supplements for at least 72 hours prior to the blood draw.
• Avoid Strenuous Exercise: Intense physical exertion within 24 hours of the test should be avoided, as acute exercise can transiently alter circulating androgen concentrations.

During the Procedure

The Dihydrotestosterone test at Lahore PCR Lab is a straightforward venipuncture procedure executed by highly trained, certified phlebotomists adhering to strict international biosafety and quality standards:

• Patient Identification and Verification: Upon arrival, the phlebotomist will verify the patient’s identity using at least two unique identifiers (e.g., full name and registration number) and confirm adherence to pre-test instructions.
• Positioning and Site Selection: The patient is seated comfortably in a specialized phlebotomy chair. The phlebotomist inspects the antecubital fossa (the crook of the elbow) to locate a suitable, prominent vein.
• Aseptic Technique: The selected site is thoroughly cleansed with a 70% isopropyl alcohol swab in a circular motion and allowed to air dry completely to prevent hemolysis of the blood sample and ensure sterility.
• Venipuncture and Sample Collection: A sterile, single-use vacuum needle is inserted gently into the vein. Blood is collected into a gold-top Serum Separator Tube (SST) or a red-top plain tube. The phlebotomist monitors the flow to ensure a sufficient sample volume is obtained.
• Post-Puncture Care: Once the tube is filled, the needle is smoothly withdrawn, and immediate manual pressure is applied to the puncture site with a sterile cotton ball or gauze pad. A hypoallergenic adhesive bandage is applied, and the patient is advised to keep it in place for at least 15 to 30 minutes.
• Specimen Processing: The collected blood sample is left to clot at room temperature for approximately 30 minutes. It is then centrifuged at Lahore PCR Lab’s temperature-controlled processing zone to separate the serum from the cellular components. The isolated serum is immediately aliquoted and prepared for quantitative analysis.

When is a Dihydrotestosterone (DHT) Test Performed?

Evaluation of Male Pattern Baldness (Androgenetic Alopecia)

Androgenetic alopecia is a genetically predetermined disorder characterized by the progressive miniaturization of scalp hair follicles under the influence of androgens. DHT is the primary culprit in this process, binding to androgen receptors within the hair follicles and shortening the anagen (growth) phase while lengthening the telogen (resting) phase. Physicians request a DHT test to determine if systemic androgen excess is contributing to accelerated hair loss, helping to guide targeted therapies such as 5-alpha-reductase inhibitors or topical anti-androgens.

Investigation of Hirsutism and Virilization in Females

Hirsutism, defined as excess terminal hair growth in women in a male-pattern distribution (such as the face, chest, and abdomen), is a common clinical manifestation of hyperandrogenism. When accompanied by virilization—which includes signs like deepening of the voice, clitoromegaly, increased muscle mass, and temporal hair thinning—it points toward a more severe underlying endocrine pathology. Measuring DHT levels helps clinicians differentiate between ovarian sources of androgens, adrenal pathologies, or peripheral hypersensitivity of target tissues.

Assessment of 5-Alpha-Reductase Deficiency

5-alpha-reductase deficiency is a rare autosomal recessive intersex condition that affects male sexual development before birth and during puberty. Individuals with this genetic mutation lack sufficient levels of the enzyme required to convert testosterone to DHT. Consequently, genetic males (46,XY) are often born with ambiguous external genitalia, leading to diagnostic challenges at birth. Measuring the ratio of testosterone to DHT, especially after human chorionic gonadotropin (hCG) stimulation, is critical in diagnosing this metabolic block.

Monitoring Prostate Health and Therapy

The prostate gland is highly dependent on DHT for its growth, maintenance, and cellular proliferation. Elevated intraprostatic DHT levels are closely linked to Benign Prostatic Hyperplasia (BPH) and can influence the progression of prostate malignancy. In patients undergoing treatment for BPH or prostate cancer using 5-alpha-reductase inhibitors (such as finasteride or dutasteride), serial DHT measurements are utilized to assess therapeutic compliance, drug efficacy, and the degree of systemic androgen suppression achieved.

Investigating Ambiguous Genitalia and Intersex Conditions

In pediatric endocrinology, the evaluation of newborns with ambiguous genitalia requires rapid, highly accurate hormonal profiling. Because DHT is indispensable for the normal masculinization of the male external genitalia in utero, its absence or deficiency results in incomplete development. A DHT test, performed alongside testosterone, karyotyping, and pelvic ultrasounds, provides the essential biochemical data required by multidisciplinary clinical teams to make accurate diagnoses and formulate appropriate management plans.

What Does a Dihydrotestosterone (DHT) Test Detect?

The quantitative measurement of Dihydrotestosterone (DHT) at Lahore PCR Lab is instrumental in detecting, diagnosing, and monitoring a wide spectrum of physiological states and clinical disorders. The test is highly sensitive to alterations in androgen synthesis, metabolism, and receptor activity, detecting:

• Androgenetic Alopecia: Elevated or highly active peripheral DHT levels causing hair follicle miniaturization.
• Polycystic Ovary Syndrome (PCOS): Functional ovarian hyperandrogenism characterized by elevated DHT, testosterone, and LH/FSH imbalances.
• 5-Alpha-Reductase Type 2 Deficiency: Characterized by normal to high testosterone levels paired with abnormally low DHT levels.
• Benign Prostatic Hyperplasia (BPH): Increased localized or systemic DHT driving non-malignant prostate enlargement.
• Androgen-Secreting Adrenal Tumors: Neoplasms of the adrenal cortex producing excessive androgen precursors that convert to DHT.
• Androgen-Secreting Ovarian Tumors: Rare ovarian neoplasms causing rapid-onset virilization and extremely high serum DHT.
• Congenital Adrenal Hyperplasia (CAH): Enzymatic defects in cortisol synthesis leading to shunting of precursors into the androgen pathway.
• Idiopathic Hirsutism: Excess hair growth in females with normal circulating androgens, indicating increased peripheral 5-alpha-reductase activity.
• Hypogonadotropic Hypogonadism: Pituitary or hypothalamic dysfunction resulting in low LH/FSH and subsequent low testosterone and DHT.
• Hypergonadotropic Hypogonadism: Primary testicular failure resulting in low DHT despite elevated gonadotropin levels.
• Androgen Insensitivity Syndrome (AIS): Genetic mutations in the androgen receptor where DHT levels may be normal or elevated, but tissues are unresponsive.
• Efficacy of Finasteride/Dutasteride Therapy: Demonstrates a significant drop in circulating DHT levels in patients adhering to treatment.
• Exogenous Testosterone Abuse: Markedly elevated DHT levels resulting from the supraphysiologic administration of synthetic testosterones.
• Premature Adrenarche: Early activation of the adrenal glands in children, leading to mild elevations in DHT and early pubic hair development.
• Ovarian Hyperthecosis: Non-neoplastic luteinization of ovarian stromal cells causing severe hyperandrogenism and high DHT.
• Anorexia Nervosa-Induced Endocrine Dysfunction: Severe nutritional deprivation leading to suppressed hypothalamic-pituitary-gonadal axis and low DHT.
• Liver Cirrhosis-Related Hormonal Imbalance: Altered steroid metabolism in the liver leading to abnormal estrogen-to-androgen ratios.
• Hyperprolactinemia: Elevated prolactin levels stimulating adrenal androgen secretion, indirectly increasing DHT.
• Cushing’s Syndrome: Cortisol excess accompanied by adrenal androgen overproduction, elevating systemic DHT.
• Constitutional Delay of Growth and Puberty: Temporarily low DHT levels in adolescents experiencing delayed physical development.

Turnaround Time and Report Access at Lahore PCR Lab

Lahore PCR Lab is committed to delivering highly accurate diagnostic insights within optimized timelines. Due to the specialized nature of the Dihydrotestosterone (DHT) assay, which requires precise chemiluminescent immunoassay (CLIA) or liquid chromatography-mass spectrometry (LC-MS/MS) methodologies, the standard turnaround time is typically within 24 to 48 hours from the time of sample collection. This timeline ensures that the sample undergoes rigorous quality control checks, duplicate testing if necessary, and final verification by a consultant pathologist.

Patients and referring physicians can access reports seamlessly through Lahore PCR Lab’s digital ecosystem. Once the report is finalized and signed off by the clinical biochemist, an automated SMS notification containing a secure download link is sent to the patient’s registered mobile number. Reports can also be accessed directly via the official Lahore PCR Lab online portal by entering the unique patient ID and password provided on the billing receipt. For convenience, physical copies of the reports are available for collection at the main laboratory facility and designated collection centers across Lahore.

Dihydrotestosterone (DHT) Test Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Adult Males (18+ years)	250 – 990 pg/mL (Assay dependent)	< 250 pg/mL (Hypogonadism, 5-alpha-reductase deficiency); > 990 pg/mL (Exogenous androgen use, receptor resistance)
Adult Females (Pre-menopausal)	24 – 368 pg/mL (Assay dependent)	> 368 pg/mL (PCOS, ovarian/adrenal tumors, idiopathic hirsutism); < 24 pg/mL (Adrenal insufficiency, ovarian failure)
Adult Females (Post-menopausal)	< 10 – 181 pg/mL	Elevated levels indicating late-onset adrenal androgen excess or androgen-producing neoplasms.
Testosterone to DHT Ratio	Typically < 10:1 to 12:1	> 20:1 (Highly suggestive of 5-alpha-reductase deficiency in pediatric or adult male evaluations)
Pediatric Males (Pre-pubertal)	< 50 pg/mL	Elevated levels indicating precocious puberty, congenital adrenal hyperplasia, or familial testotoxicosis.
Pediatric Females (Pre-pubertal)	< 29 pg/mL	Elevated levels indicating premature adrenarche or virilizing adrenal tumors.
5-Alpha-Reductase Activity	Balanced conversion of Testosterone to DHT	Suppressed activity (due to genetic deficiency or pharmacological inhibition by finasteride/dutasteride)

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Lahore PCR Lab for Dihydrotestosterone (DHT) Test?

• Advanced Diagnostic Platforms: Lahore PCR Lab utilizes state-of-the-art automated immunoassay systems that guarantee high sensitivity and specificity for low-concentration steroid hormones like DHT.
• Expert Pathologist Supervision: Every hormone panel is supervised, reviewed, and verified by experienced consultant pathologists and clinical biochemists to ensure absolute clinical accuracy.
• Strict Quality Assurance: The laboratory adheres to stringent internal quality control protocols and participates in external quality assessment schemes to maintain international testing standards.
• Convenient Digital Report Access: Patients can view, download, and share their diagnostic reports online through a secure, user-friendly web portal and receive instant SMS updates.
• Highly Trained Phlebotomists: Our phlebotomy team is specialized in pediatric and geriatric blood collection, ensuring a virtually painless and highly professional sample collection experience.
• Comprehensive Endocrine Panels: Lahore PCR Lab offers complete hormone profiling, allowing patients to test DHT alongside Testosterone, Free Testosterone, SHBG, DHEA-S, and Cortisol.
• Hygienic and Safe Environment: All collection centers and the central laboratory in Lahore maintain the highest standards of hygiene, sanitation, and infection control.
• Central and Accessible Location: Situated conveniently in Lahore, the lab offers easy accessibility, ample parking, and comfortable waiting areas for patients and their families.